Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
August 29, 2025
Madrid
New Insights in the Management of HCM: Exploring the Clinical Spectrum
August 30, 2025
Optimizing Outcomes in Patients with oHCM: The Emerging Role of Cardiac Myosin Inhibitors
August 31, 2025
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
Obesity and Comorbidities: Strategies for Effective Patient Management
Michael Crotty, MB, BCh, BAO
Ana Maria Cebrián-Cuenca, MD, PhD
Treating Obesity: Lifelong Strategies from Lifestyle to Pharmacotherapy and Surgery
Barbara McGowan, PhD, MBBS
Beyond the Scale: How to Tackle Obesity’s Comorbidities
Obesity: Unmasking the Chronic Disease Beneath the Weight
Practical Tips for GLP-1RA Therapy Success
ns-MRAs and eGFR Slope: The Kidney Perspective
Csaba P. Kovesdy, MD
Finnian R. McCausland, MD
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, MD
Mastering MRA Monitoring: The Key to Success
Summarizing multidisciplinary strategies: Where do we go from here?
Gianluigi Savarese, MD
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes
James Burton, DM, FRCP
Aaron Wong, MD
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.